Cardiovascular Risk Assessment.

Cardiology icon showing heart with electrocardiogram

Heart disease in the US (source, US Centers for Disease Control and Prevention)

Incidence: Heart disease is the leading cause of death in the US
Mortality: One person dies every 33 seconds from cardiovascular disease. About 695,000 people in the US died from heart disease in 2021 — one in every five deaths
Health care costs: Heart disease cost about $239.9 billion per year (2018 to 2019). This includes the cost of health care services, medicines and lost productivity due to death.

Heart disease is the number one cause of death wordwide¹. Early, accurate CVD risk assessment is part of established clinical care for primary prevention and disease management.

Cardiovascular risk factors include hypertension, diabetes mellitus, chronic kidney disease, obesity, cigarette smoking and family history.
The most important biomarkers for CV risk determination are lipids, including total cholesterol, triglycerides, LDL and HDL cholesterol.
Standard lipid profile testing doesn't capture all available information, according to many studies.
Instead, measuring lipoprotein particles (LDL-p) provides more accurate results, especially for people with comorbidities.

1. Minino AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. [Accessed September 12, 2012]; Natl Vital Stat Rep. 2011 59:1–126. www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_10.pdf. [PubMed]

2. Sachdeva, A., et al., Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J, 2009. 157(1): 111-117 e2.

Testing tube with metabolic network in liquid

AXINON^® lipoFIT^®. |Innovative Lipoprotein Analysis.

Precision Diagnostics.

Axinon system user in laboratory environment

Our CE-marked AXINON^® lipoFIT^® assay provides more precise information than the standard cholesterol test.

It measures concentration, size and distribution of the lipoprotein particles that carry cholesterol, as well as the quantity of triglycerides, cholesterol and phospholipids.

Available as CE-marked IVD in the EU

FAQ

AXINON^® lipoFIT^®. |Lipoprotein Test Parameters.

Standard lipid panel	Particle concentrations	Particle sizes	Metabolites
Total cholesterol LDL cholesterol HDL cholesterol Triglycerides	LVLDL-p LDL-p SLDL-p HDL-p LHDL-p	VLDL-s LDL-s HDL-s	Alanine Valine Leucine Isoleucine

More information on the AXINON^® lipoFIT^® test system

Go to FAQs

Axinon system with implemented and expandable test overview

Technology. |The AXINON^® System.

Easy. Fast. Efficient.

Million analyses worldwide using numares technology

Nuclear magnetic resonance (NMR) spectroscopy is a proven and highly accurate test technology that assesses a variety of compounds at a molecular level.

Our AXINON^® System, using FDA-cleared technology, is the core platform we use to develop diagnostic tests for illnesses stemming from metabolic dysfunction, including chronic heart, kidney and liver diseases.

This system incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy for precise results.

To date, more than 3.5 million tests have been performed worldwide using Numares technology.

Go to Technology

White Paper

White Paper AXINON^® lipoFIT^®

Name	Purpose	Lifetime	Type	Provider
_gcl_au	Used by Google AdSense to experiment with advertisement efficiency.	3 months	HTML	Google
AMP_TOKEN	Contains a token that can be used to retrieve a Client ID from AMP Client ID service. Other possible values indicate opt-out, request in progress or an error retrieving a Client ID from AMP Client ID service.	1 year	HTML	Google
_dc_gtm_--property-id--	Used by DoubleClick (Google Tag Manager) to help identify the visitors by either age, gender or interests.	2 years	HTML	Google

Targeted Metabolomics

NMR Metabolomics

AXINON^® System